Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Statement re: AbbVie’s withdrawal of recommendation

16th Oct 2014 09:00

SHIRE PLC - Statement re: AbbVie’s withdrawal of recommendation

SHIRE PLC - Statement re: AbbVie’s withdrawal of recommendation

PR Newswire

London, October 16

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION For immediate release 16 October 2014 Shire plc Statement re: AbbVie's withdrawal of recommendation The Board of Shire plc notes the announcement by AbbVie Inc. of its Board'sdecision to withdraw its recommendation of the offer for Shire. The Board of Shire is considering the current situation and a furtherannouncement will be made in due course. CONTACTS Shire Shire Media Relations: Stephanie Fagan +1 201 572 9581 Shire Investor Relations Jeff Poulton +1 781 482 0945 Sarah Elton-Farr +44 1256 894157 FTI Consulting (Media Adviser to the Company) Andrew Lorenz (London) +44 77 7564 1807 Ben Atwell (London) +44 20 3727 1000 David B. Roady (New York) +1 212 850 5600 Robert Stanislaro (New York) +1 212 850 5600 Evercore (Financial Adviser to the Company) Francois Maisonrouge +44 20 7653 6000 Edward Banks Morgan Stanley (Financial Adviser to the Company) Michele Colocci +44 20 7425 8000 Colm Donlon Peter Moorhouse (Corporate Broking) Deutsche Bank (Financial Adviser to the Company) Nick Bowers (Corporate Broking) +44 20 7545 8000 Ben Lawrence (Corporate Broking) Citi (Financial Adviser to the Company) Christopher Hite +1 212 816 1818 Goldman Sachs (Financial Adviser to the Company) Raj Shah +44 20 7774 1000 A copy of this announcement will be available at www.shire.com. The content ofthe website referred to in this announcement is not incorporated into and doesnot form part of this announcement. NOTES TO EDITORS Shire enables people with life-altering conditions to lead better lives. We provide treatments in Rare Diseases, Neuroscience, Gastrointestinal andInternal Medicine and we are developing treatments for symptomatic conditionstreated by specialist physicians in other targeted therapeutic areas. Shire's product sales from continuing operations have increased from US$2,754million in the financial year to 31 December 2008 to US$4,757 million in thefinancial year to 31 December 2013, representing a five-year compound annualgrowth rate of 11.6%. Shire's Non GAAP diluted earnings per ADS have increasedfrom US$3.86 in the financial year to 31 December 2008 to US$7.66 in thefinancial year to 31 December 2013, representing a five-year compound annualgrowth rate of 14.7%. Shire's US GAAP diluted earnings per ADS have increasedfrom US$0.86 in the financial year to 31 December 2008 to US$3.53 in thefinancial year to 31 December 2013, representing a five-year compound annualgrowth rate of 32.7%. FURTHER INFORMATION Evercore Partners International LLP ("Evercore"), which is authorised andregulated in the United Kingdom by the Financial Conduct Authority, is actingas financial adviser exclusively for Shire and no one else in connection withthe matters referred to in this announcement and will not regard any otherperson as its client in relation to the matters referred to in thisannouncement and will not be responsible to anyone other than Shire forproviding the protections afforded to clients of Evercore, nor for providingadvice in relation to the matters referred to in this announcement. Morgan Stanley & Co. International plc, which is authorised by the PrudentialRegulation Authority and regulated by the Financial Conduct Authority and thePrudential Regulation Authority in the United Kingdom, is acting as financialadviser to Shire and no one else in connection with the matters referred to inthis announcement. In connection with such matters, Morgan Stanley & Co.International plc, its affiliates and its and their respective directors,officers, employees and agents will not regard any other person as theirclient, nor will they be responsible to any other person other than Shire forproviding the protections afforded to their clients or for providing advice inconnection with the contents of this announcement or any other matter referredto herein. Citigroup Global Markets Limited, which is authorised by the PrudentialRegulation Authority and regulated by the Financial Conduct Authority and thePrudential Regulation Authority, each in the United Kingdom, is acting asfinancial adviser to Shire and for no one else in connection with the mattersset out in this announcement. In connection with such matters, Citigroup GlobalMarkets Limited, its affiliates and its and their respective directors,officers, employees and agents will not regard any other person as theirclient, nor will they be responsible to anyone other than Shire for providingthe protections afforded to its clients or for providing advice in connectionwith the contents of this announcement or any matter referred to herein. Goldman Sachs International, which is authorised by the Prudential RegulationAuthority and regulated by the Financial Conduct Authority and the PrudentialRegulation Authority in the United Kingdom, is acting as financial adviser toShire and no one else in connection with the matters referred to in thisannouncement. In connection with such matters Goldman Sachs International, itsaffiliates and its and their respective directors, officers, employees andagents will not regard any other person as their client, nor will they beresponsible to anyone other than Shire for providing the protections affordedto clients of Goldman Sachs International, or for giving advice in connectionwith the contents of this announcement or any other matter referred to herein. Deutsche Bank AG is authorised under German Banking Law (competent authority:BaFIN - Federal Financial Supervisory Authority). Deutsche Bank AG, LondonBranch is further authorised by the Prudential Regulation Authority and issubject to limited regulation by the Financial Conduct Authority and PrudentialRegulation Authority. Deutsche Bank is acting as financial adviser to Shire andno one else in connection with the contents of this Announcement and will notbe responsible to anyone other than Shire for providing the protectionsafforded to its clients or for providing advice in connection with the contentsof this Announcement or any matter referred to herein.

Related Shares:

Shire
FTSE 100 Latest
Value8,585.01
Change-17.91